ARCHIVES

Gottlieb questions ODAC’s independence.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

Abeloff Plans To Step Down As Cancer Center Director at Hopkins.

November 10, 2006

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

NCI Lists Projected Grant Paylines

February 16, 1996